Financials
Financial year 2025
Gross margin
€ 0
Profit
Healthy€ 24,715
▼ 79% vs 2024
Debts
Low€ 521,878
▲ 99% vs 2024
HistoGeneX Holding from Antwerpen, company number BE0643686060, closed financial year 2025 with a result of € 24,715 after tax. For that financial year HistoGeneX Holding recorded a gross margin of € 0 and equity of € 65.9 million. Compared with financial year 2024, the result moved from € 117,553 to € 24,715. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.
What happened at HistoGeneX Holding?
What happened at HistoGeneX Holding in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Elliot Miller stepped down as director. NBB
- Joshua Schultz stepped down as director. NBB
- Hendriks Consulting Company NV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 24,715 (▼ 79% vs 2024). Source: NBB ↗
- Maurice Tenney III stepped down as director. NBB
- Kockx Consulting NV stepped down as director. NBB
- Elliot Miller became a director. NBB
- Anthony L. Mattacchione stepped down as director. NBB
In short
From € 5 million profit in 2021 to € 24,715 profit in 2025.
Best year ever: 2021, with € 5 million profit.
Paid out € 4.8 million in dividends to the owners in total.
Pays suppliers within 162 days on average.
A new publication or filing at HistoGeneX Holding? We notify you, reason included.
Follow HistoGeneX HoldingNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 83.3% of CELLCARTA NV itself.
Directors
According to the 2025 annual accounts
since 2023 · until 2026
since 2025 · until 2031
since 2019 · until 2025
Managing director · represented by Mark Kockx
Also active at: BATYO, CellCarta, PATHOMATION +1 more
since 2021 · until 2026
since 2022 · until 2025
since 2025 · until 2030
Hendriks Consulting Company NV
Managing director · represented by Dirk Hendriks
Also active at: CellCarta, Arsenal IO Belgium
since 2021 · until 2027
Establishments
Establishment units
Physical locations of this company
Sint-Bavostraat 78
2610 Antwerpen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
DIGITALOCEAN-ASN - DigitalOcean, LLC, US
Domain
Domain
cellcarta.com
Registered
2020-07-09
Registrar
GoDaddy.com, LLC
Expires
2026-07-09
Website info
Features
Security
Details
- Company number
- 0643.686.060
- VAT number
- BE 0643.686.060
- Registered office
- Sint-Bavostraat 78, 2610 Antwerpen
- Names & denominations
- HistoGeneX Holding
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 November 2015
- Peppol
- Active · Active since 14 Oct 2025
- Contact
- cellcarta.com
- Activities · NACE
Activiteiten van holdings
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering